help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2007-0176
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
21/10/2350    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quignodon, L.
Right arrow Articles by Flamant, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quignodon, L.
Right arrow Articles by Flamant, F.
Molecular Endocrinology 21 (10): 2350-2360
Copyright © 2007 by The Endocrine Society

A Point Mutation in the Activation Function 2 Domain of Thyroid Hormone Receptor {alpha}1 Expressed after CRE-Mediated Recombination Partially Recapitulates Hypothyroidism

Laure Quignodon, Séverine Vincent, Harald Winter, Jacques Samarut and Frédéric Flamant

Institut de Génomique Fonctionnelle de Lyon (L.Q., S.V., J.S., F.F.), Université Lyon 1, Ecole Normale Supérieure de Lyon, Unité Mixte de Recherche (UMR), Centre National de la Recherche Scientifique 5242-Institut National de la Recherche Agronomique 1288, F-69364 Lyon, France; and University of Tübingen (H.W.), Tübingen Hearing Research Centre, Laboratory of Molecular Neurobiology, 72074 Tübingen, Germany

Address all correspondence and requests for reprints to: Frédéric Flamant, Institut de Génomique Fonctionnelle, Ecole Normale Supérieure de Lyon, 46 allée d’Italie, 69364 Lyon Cedex 07, France. E-mail: Frederic.Flamant{at}ens-lyon.fr.

Thyroid hormones act directly on transcription by binding to TR{alpha}1, TRß1, and TRß2 nuclear receptors, regulating many aspects of postnatal development and homeostasis. To analyze precisely the implication of the widely expressed TR{alpha}1 isoform in this pleiotropic action, we have generated transgenic mice with a point mutation in the TR{alpha}1 coding sequence, which is expressed only after CRE/loxP-mediated DNA recombination. The amino acid change prevents interaction between TR{alpha}1 and histone acetyltransferase coactivators and the release of corepressors. Early expression of this dominant-negative receptor deeply affects postnatal development and adult homeostasis, recapitulating many aspects of congenital and adult hypothyroidism, except in tissues and cells where TRß1 and TRß2 are predominantly expressed. Both respective abundance and intrinsic properties of TR{alpha}1 and TRß1/2 seem to govern specificity of action.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ
Coregulators:   SRC-1  |  GRIP1  |  NCOR
Ligands:   Thyroid hormone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society